Osteoarthritis Therapeutics Market Size, Share, Growth Analysis, By Anatomy (Knee Osteoarthritis, Hip Osteoarthritis), By Drug Type (Viscosupplementation Agents, Non-Steroidal Anti-inflammatory Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By Region -Industry Forecast 2025-2032

North America dominates the global osteoarthritis therapeutics market due to a combination of factors including a large aging population, high prevalence of osteoarthritis, and advanced healthcare infrastructure. Indeed, the region is said to receive massive healthcare spending, making most available treatment options such as biologics, NSAIDs, and viscosupplementation agents accessible. North America has also been the leading researcher and developer in the space of innovations in therapeutic solutions. Other factors such as government support for improvement in healthcare, along with increasing public awareness of osteoarthritis management, are essential in making the region inherently superior. This, combined with very developed healthcare systems, has given North America dominance over the global osteoarthritis therapeutics market.

Europe is the fastest-growing region in the global osteoarthritis therapeutics market, driven by an aging population and increasing healthcare investments across the continent. The rising incidences of osteoarthritis, particularly in the elder population, are thereby increasing the demand for advanced treatment options like biologics, viscosupplementation, regenerative therapies, etc. It can also be stated that in Europe, new and innovative healthcare solutions are emerging through collaborative research and favorable regulatory environments. The increased adoption of personalized therapies and minimally invasive treatment is some of the other major contributing factors to the overall rapid expansion of the osteoarthritis therapeutics market in Europe, which is driven by the strong focus on improving quality of life for patients.